REASONING AND DECISION-MAKING STUDIES

该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 这是一个NIMH资助和IRB批准的方案。将从Vaidya医生的患者名单和传单中招募288名7至25岁的受试者。一半的参与者（72名女性和72名男性）将患有注意力缺陷多动障碍（ADHD），并接受刺激性药物治疗至少1年。他们的诊断将通过DSM-IV标准，BCSC和ADHD评定量表进行确认。健康的非ADHD对照组将有72名女性和72名男性参与者，他们的年龄和智商匹配。如果参与者在儿童行为检查表上有内化或外化评分，或者如果他们有任何既往心理治疗或精神活性药物治疗史，则将被排除在外。第1年和第2年每年将研究100名受试者，第3年将研究88名受试者。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an NIMH-funded and IRB approved protocol. 288 subjects between the ages of 7 and 25 will be recruited from Dr. Vaidya's patient lists and by flyers. Half of the participants (72 female and 72 male) will have attention deficit hyperactivity disorder (ADHD) treated with stimulant drugs for at least 1 year. Their diagnosis will be confirmed by DSM-IV criteria, BCSC and ADHD Rating Scales. The healthy, non-ADHD control group will have 72 female and 72 male participants who will be age and IQ matched. Participants will be excluded if they have internalizing or externalizing scores on the Childhood Behavior Checklist, or if they have any history of prior psychological therapy or psychoactive drug treatment. 100 subjects per year will be studied in YEARs 1 and 2, and 88 in YEAR 3.